A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma

NCT06296121 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
252
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biocad